Moreover, murine bone marrow progenitors retrovirally transduced with poor-risk AML-associated fusion oncogenes for which no human cell lines exist, such as MOZ-TIF2 and NUP98-HOXA9 also demonstrated sensitivity (Figure 1c). This evidence concerns the gene NCOA2 and acute myeloid leukemia.